These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11745408)

  • 21. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
    Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
    Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.
    Shibina A; Seidel D; Somanchi SS; Lee DA; Stermann A; Maurer BJ; Lode HN; Reynolds CP; Huebener N
    J Mol Med (Berl); 2013 Apr; 91(4):459-72. PubMed ID: 23052481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.
    Golubkov V; Garcia A; Markland FS
    Anticancer Res; 2005; 25(1A):249-53. PubMed ID: 15816545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
    Vacca A; Ribatti D; Iurlaro M; Albini A; Minischetti M; Bussolino F; Pellegrino A; Ria R; Rusnati M; Presta M; Vincenti V; Persico MG; Dammacco F
    Int J Clin Lab Res; 1998; 28(1):55-68. PubMed ID: 9594364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
    J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.
    Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Bogenmann E; Ponzoni M; Montaldo PG
    Cancer Lett; 2003 Jul; 197(1-2):151-5. PubMed ID: 12880975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
    Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.
    Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB
    Int J Oncol; 2008 May; 32(5):1011-9. PubMed ID: 18425327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
    Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
    Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
    Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
    Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model.
    Boehle AS; Kurdow R; Schulze M; Kliche U; Sipos B; Soondrum K; Ebrahimnejad A; Dohrmann P; Kalthoff H; Henne-Bruns D; Neumaier M
    Int J Cancer; 2001 Nov; 94(3):420-8. PubMed ID: 11745424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
    Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
    Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic cytokines. Quantitative and functional analysis.
    Eggert A; Maris JH
    Methods Mol Biol; 2003; 215():117-33. PubMed ID: 12512294
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D; Williams JI; Pietras RJ
    Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.